Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Partitioning the risk of tuberculosis transmission in household contact studies.

McIntosh AI, Jenkins HE, Horsburgh CR, Jones-López EC, Whalen CC, Gaeddert M, Marques-Rodrigues P, Ellner JJ, Dietze R, White LF.

PLoS One. 2019 Oct 22;14(10):e0223966. doi: 10.1371/journal.pone.0223966. eCollection 2019.

2.

The burden of latent multidrug-resistant tuberculosis.

Garcia-Basteiro AL, Jenkins HE, Rangaka M.

Lancet Infect Dis. 2019 Aug;19(8):802-803. doi: 10.1016/S1473-3099(19)30271-3. Epub 2019 Jul 4. No abstract available. Erratum in: Lancet Infect Dis. 2019 Oct;19(10):e337.

3.

Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine.

Chiang SS, Sheremeta Y, Padilla RS, Jenkins HE, Horsburgh CR Jr, Petrenko V, Rybak NR.

J Epidemiol Glob Health. 2019 Mar;9(1):56-61. doi: 10.2991/jegh.k.190225.002.

PMID:
30932391
4.

Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study.

Dodd PJ, Yuen CM, Becerra MC, Revill P, Jenkins HE, Seddon JA.

Lancet Glob Health. 2018 Dec;6(12):e1329-e1338. doi: 10.1016/S2214-109X(18)30401-7. Epub 2018 Sep 25.

5.

Using routinely collected laboratory data to identify high rifampicin-resistant tuberculosis burden communities in the Western Cape Province, South Africa: A retrospective spatiotemporal analysis.

McIntosh AI, Jenkins HE, White LF, Barnard M, Thomson DR, Dolby T, Simpson J, Streicher EM, Kleinman MB, Ragan EJ, van Helden PD, Murray MB, Warren RM, Jacobson KR.

PLoS Med. 2018 Aug 21;15(8):e1002638. doi: 10.1371/journal.pmed.1002638. eCollection 2018 Aug.

6.

Quantifying TB transmission: a systematic review of reproduction number and serial interval estimates for tuberculosis.

Ma Y, Horsburgh CR, White LF, Jenkins HE.

Epidemiol Infect. 2018 Sep;146(12):1478-1494. doi: 10.1017/S0950268818001760. Epub 2018 Jul 4.

7.

The burden of multidrug-resistant tuberculosis in children.

Jenkins HE, Yuen CM.

Int J Tuberc Lung Dis. 2018 May 1;22(5):3-6. doi: 10.5588/ijtld.17.0357. Review.

8.

Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients.

Nguyen DT, Jenkins HE, Graviss EA.

PLoS One. 2018 Apr 16;13(4):e0196022. doi: 10.1371/journal.pone.0196022. eCollection 2018.

9.

The global burden of tuberculosis mortality in children: a mathematical modelling study.

Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE.

Lancet Glob Health. 2017 Sep;5(9):e898-e906. doi: 10.1016/S2214-109X(17)30289-9.

10.

Predictors of delayed care seeking for tuberculosis in southern India: an observational study.

Van Ness SE, Chandra A, Sarkar S, Pleskunas J, Ellner JJ, Roy G, Lakshminarayanan S, Sahu S, Horsburgh CR Jr, Jenkins HE, Hochberg NS.

BMC Infect Dis. 2017 Aug 15;17(1):567. doi: 10.1186/s12879-017-2629-9.

11.

Extensions to Bayesian generalized linear mixed effects models for household tuberculosis transmission.

McIntosh AI, Doros G, Jones-López EC, Gaeddert M, Jenkins HE, Marques-Rodrigues P, Ellner JJ, Dietze R, White LF.

Stat Med. 2017 Jul 20;36(16):2522-2532. doi: 10.1002/sim.7303. Epub 2017 Mar 29.

12.

Isoniazid-resistant tuberculosis: a cause for concern?

Stagg HR, Lipman MC, McHugh TD, Jenkins HE.

Int J Tuberc Lung Dis. 2017 Feb 1;21(2):129-139. doi: 10.5588/ijtld.16.0716. Review.

13.

Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.

Nourzad S, Jenkins HE, Milstein M, Mitnick CD.

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):6-11. doi: 10.5588/ijtld.16.0110.

14.

Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis.

Skrahin A, Jenkins HE, Hurevich H, Solodovnikova V, Isaikina Y, Klimuk D, Rohava Z, Skrahina A.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S23. doi: 10.1016/j.ijmyco.2016.11.018. Epub 2016 Nov 29.

15.

Global Burden of Childhood Tuberculosis.

Jenkins HE.

Pneumonia (Nathan). 2016;8. pii: 24. doi: 10.1186/s41479-016-0018-6. Epub 2016 Nov 24.

16.

Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis.

Jenkins HE, Yuen CM, Rodriguez CA, Nathavitharana RR, McLaughlin MM, Donald P, Marais BJ, Becerra MC.

Lancet Infect Dis. 2017 Mar;17(3):285-295. doi: 10.1016/S1473-3099(16)30474-1. Epub 2016 Dec 8. Review.

17.

Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities.

McAnaw SE, Hesseling AC, Seddon JA, Dooley KE, Garcia-Prats AJ, Kim S, Jenkins HE, Schaaf HS, Sterling TR, Horsburgh CR.

Int J Infect Dis. 2017 Mar;56:194-199. doi: 10.1016/j.ijid.2016.11.423. Epub 2016 Dec 9. Review.

18.

Two methods for setting child-focused tuberculosis care targets.

Yuen CM, Jenkins HE, Chang R, Mpunga J, Becerra MC.

Public Health Action. 2016 Jun 21;6(2):83-96. doi: 10.5588/pha.16.0022.

19.

Smear positivity in paediatric and adult tuberculosis: systematic review and meta-analysis.

Kunkel A, Abel Zur Wiesch P, Nathavitharana RR, Marx FM, Jenkins HE, Cohen T.

BMC Infect Dis. 2016 Jun 13;16:282. doi: 10.1186/s12879-016-1617-9. Review.

20.

Effectiveness of a novel cellular therapy to treat multidrug-resistant tuberculosis.

Skrahin A, Jenkins HE, Hurevich H, Solodovnikova V, Isaikina Y, Klimuk D, Rohava Z, Skrahina A.

J Clin Tuberc Other Mycobact Dis. 2016 Aug;4:21-27.

21.

Counting children with tuberculosis: why numbers matter.

Seddon JA, Jenkins HE, Liu L, Cohen T, Black RE, Vos T, Becerra MC, Graham SM, Sismanidis C, Dodd PJ.

Int J Tuberc Lung Dis. 2015 Dec;19 Suppl 1:9-16. doi: 10.5588/ijtld.15.0471. Review.

22.

Data for action: collection and use of local data to end tuberculosis.

Theron G, Jenkins HE, Cobelens F, Abubakar I, Khan AJ, Cohen T, Dowdy DW.

Lancet. 2015 Dec 5;386(10010):2324-33. doi: 10.1016/S0140-6736(15)00321-9. Epub 2015 Oct 26. Review.

23.

Global and Regional Burden of Isoniazid-Resistant Tuberculosis.

Yuen CM, Jenkins HE, Rodriguez CA, Keshavjee S, Becerra MC.

Pediatrics. 2015 Jul;136(1):e50-9. doi: 10.1542/peds.2015-0172. Epub 2015 Jun 1. Review.

24.

On the spread and control of MDR-TB epidemics: an examination of trends in anti-tuberculosis drug resistance surveillance data.

Cohen T, Jenkins HE, Lu C, McLaughlin M, Floyd K, Zignol M.

Drug Resist Updat. 2014 Oct-Dec;17(4-6):105-23. doi: 10.1016/j.drup.2014.10.001. Epub 2014 Oct 6.

25.

The burden of tuberculosis disease in children--Authors' reply.

Jenkins HE, Pagano M, Yuen CM, Becerra MC, Cohen T.

Lancet. 2014 Oct 11;384(9951):1343-4. doi: 10.1016/S0140-6736(14)61811-0. No abstract available.

PMID:
25307837
26.

Geographical heterogeneity of multidrug-resistant tuberculosis in Georgia, January 2009 to June 2011.

Jenkins HE, Gegia M, Furin J, Kalandadze I, Nanava U, Chakhaia T, Cohen T.

Euro Surveill. 2014 Mar 20;19(11). pii: 20743.

27.

Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates.

Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Pérez-Vélez CM, Pagano M, Becerra MC, Cohen T.

Lancet. 2014 May 3;383(9928):1572-9. doi: 10.1016/S0140-6736(14)60195-1. Epub 2014 Mar 24. Review.

28.

High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova.

Jenkins HE, Crudu V, Soltan V, Ciobanu A, Domente L, Cohen T.

Eur Respir J. 2014 Apr;43(4):1132-41. doi: 10.1183/09031936.00203613. Epub 2014 Feb 20.

29.

Outcomes of children treated for tuberculosis with second-line medications in Georgia, 2009-2011.

Gegia M, Jenkins HE, Kalandadze I, Furin J.

Int J Tuberc Lung Dis. 2013 May;17(5):624-9. doi: 10.5588/ijtld.12.0792.

30.

Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova.

Jenkins HE, Ciobanu A, Plesca V, Crudu V, Galusca I, Soltan V, Cohen T.

Int J Tuberc Lung Dis. 2013 Mar;17(3):373-80. doi: 10.5588/ijtld.12.0464.

31.

Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country.

Jenkins HE, Plesca V, Ciobanu A, Crudu V, Galusca I, Soltan V, Serbulenco A, Zignol M, Dadu A, Dara M, Cohen T.

Eur Respir J. 2013 Nov;42(5):1291-301. doi: 10.1183/09031936.00111812. Epub 2012 Oct 25.

32.

Direction of association between bite wounds and Mycobacterium bovis infection in badgers: implications for transmission.

Jenkins HE, Cox DR, Delahay RJ.

PLoS One. 2012;7(9):e45584. doi: 10.1371/journal.pone.0045584. Epub 2012 Sep 19.

33.

Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994-2009.

Jenkins HE, Zignol M, Cohen T.

PLoS One. 2011;6(7):e22927. doi: 10.1371/journal.pone.0022927. Epub 2011 Jul 29.

34.

Implications of a circulating vaccine-derived poliovirus in Nigeria.

Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Mwanza M, Corander J, Garnier S, Chauvin C, Abanida E, Pate MA, Adu F, Baba M, Grassly NC.

N Engl J Med. 2010 Jun 24;362(25):2360-9. doi: 10.1056/NEJMoa0910074. Erratum in: N Engl J Med. 2010 Sep 23;363(13):1290.

35.

The duration of the effects of repeated widespread badger culling on cattle tuberculosis following the cessation of culling.

Jenkins HE, Woodroffe R, Donnelly CA.

PLoS One. 2010 Feb 10;5(2):e9090. doi: 10.1371/journal.pone.0009090.

36.

Social group size affects Mycobacterium bovis infection in European badgers (Meles meles).

Woodroffe R, Donnelly CA, Wei G, Cox DR, Bourne FJ, Burke T, Butlin RK, Cheeseman CL, Gettinby G, Gilks P, Hedges S, Jenkins HE, Johnston WT, McInerney JP, Morrison WI, Pope LC.

J Anim Ecol. 2009 Jul;78(4):818-27. doi: 10.1111/j.1365-2656.2009.01545.x. Epub 2009 Mar 30.

37.

Pandemic potential of a strain of influenza A (H1N1): early findings.

Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Jombart T, Hinsley WR, Grassly NC, Balloux F, Ghani AC, Ferguson NM, Rambaut A, Pybus OG, Lopez-Gatell H, Alpuche-Aranda CM, Chapela IB, Zavala EP, Guevara DM, Checchi F, Garcia E, Hugonnet S, Roth C; WHO Rapid Pandemic Assessment Collaboration.

Science. 2009 Jun 19;324(5934):1557-61. doi: 10.1126/science.1176062. Epub 2009 May 11.

38.

Bovine tuberculosis in cattle and badgers in localized culling areas.

Woodroffe R, Donnelly CA, Cox DR, Gilks P, Jenkins HE, Johnston WT, Le Fevre AM, Bourne FJ, Cheeseman CL, Clifton-Hadley RS, Gettinby G, Hewinson RG, McInerney JP, Mitchell AP, Morrison WI, Watkins GH.

J Wildl Dis. 2009 Jan;45(1):128-43.

39.

Effectiveness of immunization against paralytic poliomyelitis in Nigeria.

Jenkins HE, Aylward RB, Gasasira A, Donnelly CA, Abanida EA, Koleosho-Adelekan T, Grassly NC.

N Engl J Med. 2008 Oct 16;359(16):1666-74. doi: 10.1056/NEJMoa0803259.

40.

The effects of annual widespread badger culls on cattle tuberculosis following the cessation of culling.

Jenkins HE, Woodroffe R, Donnelly CA.

Int J Infect Dis. 2008 Sep;12(5):457-65. doi: 10.1016/j.ijid.2008.04.001. Epub 2008 May 27.

41.

The prevalence, distribution and severity of detectable pathological lesions in badgers naturally infected with Mycobacterium bovis.

Jenkins HE, Morrison WI, Cox DR, Donnelly CA, Johnston WT, Bourne FJ, Clifton-Hadley RS, Gettinby G, McInerney JP, Watkins GH, Woodroffe R.

Epidemiol Infect. 2008 Oct;136(10):1350-61. Epub 2007 Nov 30.

42.

Impacts of widespread badger culling on cattle tuberculosis: concluding analyses from a large-scale field trial.

Donnelly CA, Wei G, Johnston WT, Cox DR, Woodroffe R, Bourne FJ, Cheeseman CL, Clifton-Hadley RS, Gettinby G, Gilks P, Jenkins HE, Le Fevre AM, McInerney JP, Morrison WI.

Int J Infect Dis. 2007 Jul;11(4):300-8. Epub 2007 Jun 12.

43.

Culling and cattle controls influence tuberculosis risk for badgers.

Woodroffe R, Donnelly CA, Jenkins HE, Johnston WT, Cox DR, Bourne FJ, Cheeseman CL, Delahay RJ, Clifton-Hadley RS, Gettinby G, Gilks P, Hewinson RG, McInerney JP, Morrison WI.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14713-7. Epub 2006 Oct 2.

Supplemental Content

Loading ...
Support Center